Infectious Disease Control
LANDMARK GLOBAL STUDY REVEALS CRITICAL INEQUITIES IN ACCESS TO DERMATOLOGICAL CARE
First comprehensive global assessment by the International League of
Dermatological Societies (ILDS) and L'Oréal Dermatological Beauty spans 158
countries and 97% of the world's population.
Summary: The Global Access to Skin Health Observatory Study
2026-09-16 17:00
641
GHIT Fund Launches "NTDpedia" to Help Turn Apathy Into Action Against Neglected Tropical Diseases
The interactive educational website makes NTDs understandable to a general audience, the first step toward public support that drives R&D for the 1.5 billion people affected by these diseases TOKYO, Sept. 16, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced the ...
2026-09-16 13:00
895
Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine. MAIDENHEAD, United Kingdom, Sept. 11, 2026 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL; USOTC: CSLLY), today announced ...
2026-09-11 06:51
3549
Dr Hanan H. Balkhy Launches Candidacy for WHO Director-General, Pledges "A WHO the World Can Count On"
* Nominated by the Kingdom of Saudi Arabia * A physician trained in Saudi Arabia and the United States, with more than 30 years of experience spanning clinical medicine, academic research and international public health leadership * WHO Regional Director for the Eastern Mediterranean sets ou...
2026-09-10 20:55
2082
Singapore has cut stroke mortality by up to six-fold since the 1990s, but public awareness remains the final hurdle, new report finds
Singaporean experts call for renewed public education on the FAST warning signs and continued investment in specialist staffing to sustain the country's world-leading stroke outcomes. SINGAPORE, Sept. 2, 2026 /PRNewswire/ -- Singapore has cut stroke mortality by up to six-fold since the 1990s[1]...
2026-09-02 15:00
4944
Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)
* STAgora™ analysis of approximately 60,000 test results collected over 42 months showed that STI pathogens were detected in 82% of HPV-positive cases * Findings support the potential value of a comprehensive testing approach that provides both HPV and STI pathogen information * Seegene to v...
2026-07-27 21:00
6801
PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS
OSLO, Norway, July 23, 2026 /PRNewswire/ -- Public trust in health innovation
may be less predictable than healthcare organizations assume, according to new
research from DNV, the independent assurance and certification provider.
2026-07-23 20:34
1777
GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB
TOKYO, July 23, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of JPY 140 million (approximately USD 862,000) in a project to develop a portable rapid diagnostic system for Ebola disease. The system is being jointly developed by Osaka Metrop...
2026-07-23 12:01
2035
MASSPHOTON Launches the Industry's First 200 LPM UVC LED Water Disinfection System, Independently Certified for High-Flow Applications
HONG KONG, June 30, 2026 /PRNewswire/ -- MASSPHOTON has officially introduced its new MP-UVC-200LP series UVC LED water disinfection system, delivering a maximum flow rate of up to 200 LPM per unit—setting a new benchmark for high-flow UVC LED water disinfection technology. Featuring mercury-free...
2026-06-30 18:05
2075
Six Regional Organisations Sign MoU to Strengthen Asia's Dengue Response as Cases Rise
Announced at the 9th Asia Dengue Summit in conjunction with ASEAN Dengue Day and the first WHO-recognised World Dengue Day, the MoU establishes a regional framework for knowledge-sharing, advocacy and coordinated dengue action. SINGAPORE, June 15, 2026 /PRNewswire/ -- The Asia Dengue Voice an...
2026-06-15 19:30
6677
Duke-NUS awarded €2 million EU grant to help Asia detect outbreaks earlier through wastewater surveillance
EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge SINGAPORE, June 9, 2026 /PRNewswire/ -- Duke-NUS Medical School has secured a €2 million EU grant to help countries across Asia strengthen their ability to detect infe...
2026-06-09 16:31
6726
Ebola disease in Democratic Republic of Congo: MSF scales up response to a rapidly evolving outbreak
HONG KONG, June 1, 2026 /PRNewswire/ -- In eastern Democratic Republic of Congo (DRC), people have been living through insecurity and with an under-resourced health system for years. The Ebola disease outbreak due to the Bundibugyo virus – which does not yet have approved vaccines or specific tre...
2026-06-01 18:06
6442
Wincomm Secures Computex Best Choice Award for Three Consecutive Years (2024-2026), Leading the Future of AI-Powered Medical Solutions
HSINCHU, May 21, 2026 /PRNewswire/ -- Wincomm Corporation, a global leader in medical and industrial computing, is proud to announce it has achieved a prestigious milestone by winning the Computex Best Choice Award (BC Award) for three consecutive years from 2024 to 2026. This hat-trick of accola...
2026-05-21 15:16
4901
FDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant Pathogens
SANTA MARIA, Calif. and GUIPRY, France, Feb. 18, 2026 /PRNewswire/ -- In a major step forward against Antimicrobial Resistance (AMR), NG Biotech, in partnership with Hardy Diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designations to...
2026-02-18 20:43
8653
Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for the development of drugs, diagnostics and vaccines for malaria, tuberculosis (TB), and neglected ...
2026-02-03 09:00
6745
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
* Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family * Next-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle technology * SK bioscience will continue to strengthen a Mid- to Long-Term global vaccine...
2026-01-29 10:10
7977
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximatelyJPY 70 million (USD 460,0001) for the development of a prototype detection test for mpox (formerly known as monkeypox2). Mpox is a viral infectious disease that h...
2025-12-08 09:00
1820
/C O R R E C T I O N -- Seegene Inc./
In the news release, "Seegene Establishes French Subsidiary to Expand European Footprint", issued05-Dec-2025 by Seegene Inc. over PR Newswire, we are advised by the company that the first sub-headline should read "France becomes Seegene's eighth overseas sales subsidiary and third inEurope, follo...
2025-12-06 00:00
6013
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current therapies These are the first global Phase 3 studies of a long-acting anti-TSLP antibody, marking a pivotal step as GB-0895 advances the pro...
2025-12-01 19:00
2951
Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University
TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 1.73 billion (USD 11.6 million1) in four R&D projects for the development of diagnostics and a vaccine for tuberculosis (TB), neglected tropical diseases...
2025-10-29 10:00
1977
Week's Top Stories
Most Reposted
Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
[Picked up by 287 media titles]
2026-09-15 11:00
Futurise Impact Report 2025 Highlights Progress in Regulatory Innovation Future-Ready Technologies
[Picked up by 272 media titles]
2026-09-09 13:26
Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing
[Picked up by 264 media titles]
2026-09-10 15:00New ASEAN Study Reveals Businesses Are Rethinking Hiring and Investment as Growth Priorities Shift
[Picked up by 260 media titles]
2026-09-10 07:45
CLP Power Hosts AESIEAP CEO Conference 2026 in Hong Kong
[Picked up by 259 media titles]
2026-09-15 19:07
Most Read
ALLSWIFIT Introduces ActiveRise+, a Stable Carbon-Plate Running Shoe Built to Help Everyday Runners Train Smarter and Run Stronger
2026-09-11 21:00
12465
